Ligand Design for Modulation of RXR Functions

Area of Science:

• Molecular Biology
• Endocrinology
• Drug Discovery

Background:

• Retinoid X receptors (RXRs) are nuclear receptors known for their versatile heterodimerization capabilities.
• RXRs interact with various nuclear receptor (NR) superfamily members, influencing gene transcription.
• RXR ligands, or rexinoids, modulate these interactions, acting as activators or synergists.

Purpose of the Study:

• To describe the rationale behind the structural diversity in rexinoid design.
• To highlight new generations of rexinoids targeting specific receptor surfaces.
• To explore the therapeutic potential of diverse rexinoids, including agonists and selective modulators.

Main Methods:

• X-ray crystallography of RXR-ligand complexes.
• High-throughput screening (HTS) for ligand discovery.
• Molecular modeling and rational drug design.
• Characterization of novel rexinoids and their interactions.

Main Results:

• A wide structural diversity of rexinoids has been explored, derived from various sources.
• New rexinoids are capable of modulating RXR surface structures for targeted regulation.
• The study outlines a panel of RXR agonists, partial agonists, and selective rexinoids.

Conclusions:

• Diverse rexinoid design strategies are crucial for exploring RXR's therapeutic landscape.
• Targeting specific RXR surfaces with novel ligands presents a promising therapeutic avenue.
• Further exploration of rexinoid potential is needed to overcome current therapeutic limitations.